Impacts of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of apixaban in patients with non-valvular atrial fibrillation.
Junichi NakagawaTakahiko KinjoNaoya AiuchiKayo UenoHirofumi TomitaTakenori NiiokaPublished in: European journal of clinical pharmacology (2022)
/D of apixaban, but these effects were found to be small.